Ozempic, Wegovy, Mounjaro, and Zepbound are weekly shot medications, containing semaglutide or tirzepatide to mimic GLP-1 and GIP hormones, aiding in weight loss by curbing hunger signals.
Not all users experience weight loss or blood sugar control improvements with these drugs. Response variations challenge predicting who will benefit, according to Dr. Scott Hagan of the University of Washington.
Collection
[
|
...
]